Study on the effect of rituximab for steroid-dependent nephrotic syndrome

Study on the effect of rituximab for steroid-dependent nephrotic syndrome - R-SDNS Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017470

Enrollment

Registered

2015-05-08

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

steroid-dependent nephrotic syndrome

Interventions

Administration of rituximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patietns with primary nephrotic syndrome 2. Patients who had a history of frequent relapse 3. Patients who provided written informed consent for participating this study.

Exclusion criteria

Exclusion criteria: 1. Patients who had a history of severe anaphylactic reaction 2. Patients with severe heart disease, hepatic dysfunction and respiratory dysfunction 3. Patients with hepatitis B virus carrier or infection 4. Patients who are pregnant or lactating 5. Patients who are not eligible for this study at the discretion of the investigator

Design outcomes

Primary

Measure	Time frame
Duration of remission	—

Countries

Japan

Contacts

Public ContactKazuhiko Tsuruya

Graduate School Medical Sciences, Kyushu University Department of Integrated Therapy for Chronic Kidney Disease

tsuruya@intmed2.med.kyushu-u.ac.jp092-642-5843

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026